|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
85.500 +6.100 (+7.683%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 2.760% | -0.448% | -5.379% | -12.883% | -19.436% |
| ROAE (%) | 5.011% | -0.738% | -8.839% | -20.695% | -28.558% |
| Return on Capital Employed (%) | 2.809% | -0.549% | -6.365% | -15.467% | -20.682% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 86.535% | 83.971% | 81.691% | 79.567% | 88.165% |
| EBITDA Margin (%) | 9.032% | 0.280% | -20.106% | -45.662% | -61.033% |
| Pre-tax Profit Margin (%) | 6.433% | -0.834% | -18.440% | -47.636% | -61.871% |
| Net Profit Margin (%) | 6.238% | -1.004% | -16.563% | -47.829% | -63.909% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 2.625 X | 2.351 X | 2.999 X | 3.288 X | 3.787 X |
| Quick Ratio (X) | 2.470 X | 2.163 X | 2.783 X | 2.880 X | 3.345 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 48.173% | 39.277% | 39.267% | 38.996% | 36.404% |
| Total Debt / Total Assets (%) | 7.539% | 13.105% | 17.552% | 18.355% | 15.372% |
| Net Debt / Total Assets (%) | -38.902% | -21.651% | -31.180% | -33.739% | -36.200% |
| Total Debt / Shareholders' Funds (%) | 14.547% | 21.582% | 28.900% | 30.089% | 24.171% |
| Long Term Debt / Shareholders' Funds (%) | 10.413% | 18.426% | 19.159% | 21.567% | 20.422% |
| Net Debt / Shareholders' Funds (%) | -75.061% | -35.655% | -51.339% | -55.306% | -56.921% |
| Net Cash / (Debt) ($) | 14.529B | 4.677B | 6.432B | 5.934B | 5.880B |
| Net Cash / (Debt) per share ($) | 8.376 | 2.855 | 3.966 | 3.867 | 4.022 |
| Total Debt / Capital Employed (%) | 9.723% | 16.427% | 22.417% | 22.914% | 18.925% |
| Interest Coverage Ratio (X) | -- | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 220.734 Day | 216.342 Day | 384.986 Day | 544.197 Day | 741.394 Day |
| Receivables Turnover (Day) | 40.557 Day | 42.426 Day | 46.497 Day | 61.830 Day | 61.711 Day |
| Payables Turnover (Day) | 11.926 Day | 14.144 Day | 20.531 Day | 20.855 Day | 13.493 Day |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 813,565 |
| %Change | -- |
| EPS / (LPS) | RMB 0.480 |
| NBV Per Share (¥) | RMB 11.159 |